Special Life Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -82.06%
- Profit Growth -3816.93%
- Ebitda -157.25%
- Net Worth -42.50%
- Total Assets -35.71%
About Special Life Pharmaceuticals
Special Life Pharmaceuticals Private Limited (SLPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 October 2018 (Six years and three months 10 days old ). Its registered office is in Champaran, Bihar, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Kumar, Poonam Kumari, and Niki Kumari serve as directors at the Company.
Company Details
-
Location
Champaran, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999BR2018PTC039770
-
Company No.
039770
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Oct 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Special Life Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Kumar
|
Director | 24-Oct-2018 | Current |
|
Poonam Kumari
|
Additional Director | 07-Mar-2019 | Current |
|
Niki Kumari
|
Additional Director | 07-Mar-2019 | Current |
Financial Performance of Special Life Pharmaceuticals.
Special Life Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 82.06% decrease. The company also saw a substantial fall in profitability, with a 3816.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Special Life Pharmaceuticals?
Unlock access to Special Life Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Rasy Rays Construction Private LimitedPoonam Kumari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Special Life Pharmaceuticals?
Unlock and access historical data on people associated with Special Life Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Special Life Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Special Life Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
